CIBC World Market’s AstraZeneca AZN Stock Holding History

CIBC World Market’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$9.15M	Buy	48,924 +2,241	+5%	+$422K	0.01%	463
2026 Q1	$9.07M	Buy	46,683 +11,153	+31%	+$2.15M	0.01%	423
2025 Q4	$6.53M	Buy	35,530 +3,319	+10%	+$582K	0.01%	508
2025 Q3	$4.94M	Buy	32,211 +5,699	+21%	+$863K	0.01%	587
2025 Q2	$3.71M	Buy	26,512 +3,757	+17%	+$527K	0.01%	586
2025 Q1	$3.34M	Sell	22,755 -339	-1%	-$49K	0.01%	594
2024 Q4	$3.03M	Sell	23,094 -24,272	-51%	-$3.4M	0.01%	632
2024 Q3	$7.38M	Buy	47,366 +3,561	+8%	+$575K	0.02%	395
2024 Q2	$6.83M	Buy	43,805 +27,128	+163%	+$4.08M	0.02%	379
2024 Q1	$2.26M	Sell	16,677 -1,031	-6%	-$137K	0.01%	617
2023 Q4	$2.38M	Sell	17,708 -2,731	-13%	-$355K	0.01%	563
2023 Q3	$2.77M	Sell	20,439 -178	-0.9%	-$24.3K	0.01%	500
2023 Q2	$2.95M	Buy	20,617 +2,941	+17%	+$433K	0.01%	499
2023 Q1	$2.45M	Buy	17,676 +830	+5%	+$112K	0.01%	522
2022 Q4	$2.28M	Sell	16,846 -24,975	-60%	-$3.13M	0.01%	542
2022 Q3	$4.59M	Sell	41,821 -17,812	-30%	-$2.26M	0.02%	357
2022 Q2	$7.88M	Sell	59,633 -1,118	-2%	-$147K	0.03%	275
2022 Q1	$8.06M	Buy	60,751 +44,196	+267%	+$5.3M	0.03%	284
2021 Q4	$1.93M	Sell	16,555 -113	-0.7%	-$13.3K	0.01%	623
2021 Q3	$2M	Buy	16,668 +650	+4%	+$75.7K	0.01%	590
2021 Q2	$1.92M	Sell	16,018 -10,868	-40%	-$1.19M	0.01%	605
2021 Q1	$2.67M	Sell	26,886 -12,650	-32%	-$1.27M	0.01%	509
2020 Q4	$3.95M	Buy	39,536 +1,311	+3%	+$139K	0.01%	415
2020 Q3	$4.19M	Buy	38,225 +1,536	+4%	+$171K	0.02%	337
2020 Q2	$3.88M	Buy	36,689 +6,477	+21%	+$669K	0.02%	338
2020 Q1	$2.7M	Sell	30,212 -5,484	-15%	-$516K	0.01%	350
2019 Q4	$3.56M	Buy	35,696 +5,707	+19%	+$537K	0.01%	378
2019 Q3	$2.67M	Buy	29,989 +1,370	+5%	+$119K	0.01%	403
2019 Q2	$2.36M	Sell	28,619 -1,106	-4%	-$86.7K	0.01%	445
2019 Q1	$2.4M	Sell	29,725 -17,094	-37%	-$1.35M	0.01%	459
2018 Q4	$3.56M	Buy	46,819 +3,676	+9%	+$287K	0.02%	320
2018 Q3	$3.41M	Buy	43,143 +403	+0.9%	+$30.5K	0.01%	372
2018 Q2	$3M	Sell	42,740 -435	-1%	-$31.3K	0.01%	394
2018 Q1	$3.02M	Buy	43,175 +25,012	+138%	+$1.73M	0.01%	363
2017 Q4	$1.26M	Buy	18,163 +3,177	+21%	+$214K	0.01%	381
2017 Q3	$1.01M	Sell	14,986 -36,101	-71%	-$2.28M	﹤0.01%	395
2017 Q2	$3.48M	Buy	51,087 +23,055	+82%	+$1.51M	0.01%	344
2017 Q1	$1.75M	Sell	28,032 -4,627	-14%	-$269K	0.01%	453
2016 Q4	$1.78M	Buy	32,659 +7,764	+31%	+$441K	0.01%	457
2016 Q3	$1.64M	Buy	24,895 +7,282	+41%	+$476K	0.01%	403
2016 Q2	$1.06M	Buy	+17,613	New	+$1.02M	﹤0.01%	478
2016 Q1	–	Sell	-17,984	Closed	-$1.22M	–	870
2015 Q4	$1.22M	Sell	17,984 -3,274	-15%	-$215K	0.01%	435
2015 Q3	$1.35M	Buy	21,258 +141	+0.7%	+$9.28K	0.01%	383
2015 Q2	$1.34M	Buy	+21,117	New	+$1.45M	0.01%	432
2015 Q1	–	Sell	-20,402	Closed	-$1.44M	–	821
2014 Q4	$1.44M	Sell	20,402 -650	-3%	-$46.5K	0.01%	373
2014 Q3	$1.5M	Sell	21,052 -99	-0.5%	-$7.25K	0.01%	331
2014 Q2	$1.57M	Sell	21,151 -35,212	-62%	-$2.55M	0.01%	323
2014 Q1	$3.66M	Sell	56,363 -1,906	-3%	-$123K	0.01%	191
2013 Q4	$3.46M	Buy	58,269 +15,514	+36%	+$843K	0.01%	181
2013 Q3	$2.22M	Buy	42,755 +1,058	+3%	+$53.1K	0.01%	221
2013 Q2	$1.97M	Buy	+41,697	New	+$2.12M	0.01%	214

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

CIBC World Market's AZN Position: Q2 2026 in Review

CIBC World Market increased its AstraZeneca (AZN) stake by 4.8% in Q2 2026, buying an estimated $422K and bringing the position to 48,924 shares worth $9.15M. The position accounts for 0.01% of the portfolio, ranked #463.

CIBC World Market first reported a position in AZN in Q2 2013 and has held it in 51 quarters since. 1,495 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

CIBC World Market held 48,924 shares of AstraZeneca worth $9.15M as of Q2 2026.
CIBC World Market bought 2,241 AstraZeneca shares in Q2 2026, an estimated $422K.
AstraZeneca made up 0.01% of CIBC World Market's portfolio in Q2 2026, its #463 holding.
CIBC World Market first reported a position in AstraZeneca in Q2 2013 and has held it in 51 quarters since.
1,495 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.